PHARMACIE DES PAGODES: what changed
What changed
PHARMACIE DES PAGODES
NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparations
filed annual accounts (NBB)
Net result for the year
€2,425
2024 · -€44,220+€46,645
Equity
€11,549
2024 · €9,124+€2,425
Cash
€55,464
2024 · €10,067+€45,397
Balance sheet total
€383,064
2024 · €346,405+€36,659
Largest movements
Assets
- Cash +€45,397
up €45,397 (+451%), from €10,067 to €55,464
mainly Depreciation (+€25,770) and Trade debts (+€25,279)
- Intangible fixed assets -€25,048
down €25,048 (-39.8%), from €62,890 to €37,842
- Receivables within one year +€15,941
up €15,941 (+8.6%), from €185,759 to €201,700
of which Trade receivables: +€28,849
Equity and liabilities
- Trade debts +€25,279
up €25,279 (+8.8%), from €287,340 to €312,618
- Tax, wage and social debts +€8,275
up €8,275 (+26.0%), from €31,787 to €40,062
of which Taxes: +€6,825
Income statement
- Staff costs -€53,747
down €53,747 (-31.3%), from €171,895 to €118,148
- Gross operating margin -€7,046
down €7,046 (-4.4%), from €159,112 to €152,066
- Taxes +€6,046
new in 2025: €6,046
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
-€44,220
Gross operating margin
-€7,046
Staff costs
+€53,747
Depreciation
-€612
Other operating charges
+€318
Other operating items
+€5,663
Financial income
-€628
Financial charges
+€1,249
Taxes
-€6,046
Result 2025
€2,425
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€47,890
Investment
-€2,493
Financing
€0
Cash 2024
€10,067
From operations (derived)
+€47,890
Net result for the year
+€2,425
Depreciation
+€25,770
Stocks and contracts
+€1,475
Receivables within one year
-€15,941
Deferred charges and accrued income
-€73
Trade debts
+€25,279
Tax, wage and social debts
+€8,275
Accrued charges and deferred income
+€679
Investment (derived)
-€2,493
Investment in fixed assets (net)
-€2,493
Cash 2025
€55,464
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €346,405 | €383,064 | +€36,659 | +10.6% |
| Fixed assets | 21/28 | €63,861 | €40,585 | -€23,277 | -36.4% |
| Intangible fixed assets | 21 | €62,890 | €37,842 | -€25,048 | -39.8% |
| Tangible fixed assets | 22/27 | - | €1,771 | +€1,771 | |
| Plant, machinery and equipment | 23 | - | €1,771 | +€1,771 | |
| Financial fixed assets | 28 | €971 | €971 | = | 0.0% |
| Current assets | 29/58 | €282,544 | €342,479 | +€59,936 | +21.2% |
| Stocks and contracts in progress | 3 | €86,068 | €84,593 | -€1,475 | -1.7% |
| Stocks | 30/36 | €86,068 | €84,593 | -€1,475 | -1.7% |
| Amounts receivable within one year | 40/41 | €185,759 | €201,700 | +€15,941 | +8.6% |
| Trade receivables | 40 | €78,320 | €107,169 | +€28,849 | +36.8% |
| Other amounts receivable | 41 | €107,439 | €94,531 | -€12,908 | -12.0% |
| Cash at bank and in hand | 54/58 | €10,067 | €55,464 | +€45,397 | +451% |
| Deferred charges and accrued income | 490/1 | €650 | €722 | +€73 | +11.2% |
| Total equity and liabilities | 10/49 | €346,405 | €383,064 | +€36,659 | +10.6% |
| Equity | 10/15 | €9,124 | €11,549 | +€2,425 | +26.6% |
| Contributions | 10/11 | €200,000 | €200,000 | = | 0.0% |
| Capital | 10 | €200,000 | €200,000 | = | 0.0% |
| Issued capital | 100 | €200,000 | €200,000 | = | 0.0% |
| Reserves | 13 | €18,908 | €18,908 | = | 0.0% |
| Non-distributable reserves | 130/1 | €18,908 | €18,908 | = | 0.0% |
| Legal reserve | 130 | €18,908 | €18,908 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€209,784 | -€207,359 | +€2,425 | +1.2% |
| Amounts payable | 17/49 | €337,281 | €371,515 | +€34,234 | +10.1% |
| Amounts payable within one year | 42/48 | €337,126 | €370,680 | +€33,554 | +10.0% |
| Trade debts | 44 | €287,340 | €312,618 | +€25,279 | +8.8% |
| Suppliers | 440/4 | €287,340 | €312,618 | +€25,279 | +8.8% |
| Taxes, remuneration and social security | 45 | €31,787 | €40,062 | +€8,275 | +26.0% |
| Taxes | 450/3 | €3,449 | €10,274 | +€6,825 | +198% |
| Remuneration and social security | 454/9 | €28,338 | €29,788 | +€1,450 | +5.1% |
| Other amounts payable | 47/48 | €18,000 | €18,000 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €155 | €835 | +€679 | +438% |
| Non-recurring operating income | 76A | €9,070 | €3,145 | -€5,925 | -65.3% |
| Remuneration, social security and pensions | 62 | €171,895 | €118,148 | -€53,747 | -31.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €25,158 | €25,770 | +€612 | +2.4% |
| Other operating charges | 640/8 | €717 | €400 | -€318 | -44.3% |
| Non-recurring operating charges | 66A | €5,663 | - | -€5,663 | |
| Gross operating margin | 9900 | €159,112 | €152,066 | -€7,046 | -4.4% |
| Operating profit (loss) | 9901 | -€44,321 | €7,749 | +€52,070 | |
| Financial income | 75/76B | €3,476 | €2,847 | -€628 | -18.1% |
| Recurring financial income | 75 | €3,476 | €2,847 | -€628 | -18.1% |
| Financial charges | 65/66B | €3,375 | €2,125 | -€1,249 | -37.0% |
| Recurring financial charges | 65 | €3,375 | €2,125 | -€1,249 | -37.0% |
| Profit (loss) for the period before taxes | 9903 | -€44,220 | €8,471 | +€52,690 | |
| Income taxes | 67/77 | - | €6,046 | +€6,046 | |
| Profit (loss) for the period | 9904 | -€44,220 | €2,425 | +€46,645 | |
| Profit (loss) for the period to be appropriated | 9905 | -€44,220 | €2,425 | +€46,645 |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.